Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF beta-endorphin-like immunoreactivity in delirium.

H Koponen1, U Stenbäck, E Mattila

  • 1Department of Neurology, University of Kuopio, Finland.

Biological Psychiatry
|April 1, 1989
PubMed
Summary

Cerebrospinal fluid beta-endorphin-like immunoreactivity (CSF BLI) levels were lower in patients with delirium. Lower CSF BLI correlated with poorer cognitive function, suggesting a role for beta-endorphin system dysfunction in delirium.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined Evidence for a Long-Term, Clinical Slowing Effect of Multinutrient Intervention in Prodromal Alzheimer's Disease: Post-Hoc Analysis of 3-Year Data from the LipiDiDiet Trial.

The journal of prevention of Alzheimer's disease·2023
Same author

Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress.

The journal of prevention of Alzheimer's disease·2022
Same author

5-Year health-related quality of life outcome in patients with idiopathic normal pressure hydrocephalus.

Journal of neurology·2021
Same author

Midlife improvements in financial situation are associated with a reduced dementia risk later in life: the CAIDE 30-year study.

International psychogeriatrics·2019
Same author

Alzheimer's Disease Composite Score: A Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2019
Same author

Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2019

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Delirium is a common neuropsychiatric disorder characterized by acute confusion and altered consciousness.
  • The underlying pathophysiology of delirium remains incompletely understood.
  • The role of endogenous opioid systems, such as beta-endorphins, in delirium has not been extensively investigated.

Purpose of the Study:

  • To investigate the levels of beta-endorphin-like immunoreactivity (BLI) in the cerebrospinal fluid (CSF) of patients with delirium.
  • To explore the relationship between CSF BLI levels and cognitive functioning in delirious patients.

Main Methods:

  • Cerebrospinal fluid (CSF) samples were collected from 69 patients diagnosed with delirium based on DSM-III criteria.
  • CSF BLI levels were measured using a validated immunoassay.

Related Experiment Videos

  • Cognitive functioning was assessed using the Mini-Mental State Examination (MMSE).
  • Statistical analyses were performed to compare CSF BLI levels between patients and controls and to examine correlations with clinical variables.

    • Main Results:

    • Patients with delirium exhibited significantly lower CSF BLI levels compared to healthy controls (12.5 +/- 3.0 pg/ml vs. 15.0 +/- 3.4 pg/ml, p < 0.05).
    • CSF BLI levels did not correlate with patient age or neuroleptic medication dosage.
    • A significant positive correlation was observed between CSF BLI levels and Mini-Mental State scores, indicating better cognitive function with higher BLI.

    Conclusions:

    • The findings suggest that reduced beta-endorphinergic activity in the central nervous system may contribute to the development of delirium.
    • Beta-endorphinergic dysfunction is a potential pathophysiological mechanism underlying delirium.
    • Further research is warranted to elucidate the precise role of the beta-endorphin system in delirium and its potential as a therapeutic target.